Video

Q&A With Luca Prosperini From Sapienza University: Improving Multiple Sclerosis Treatment Through Medication And Video Games

Author(s):

Newer medications for the treatment of multiple sclerosis have been developed in recent years but for some patients interferon remains the starting point for pharmaceutical options.

Newer medications for the treatment of multiple sclerosis have been developed in recent years but for some patients interferon remains the starting point for pharmaceutical options.

Luca Prosperini, MD, PhD, from Sapienza University in Rome discussed these and other topics during the recent ECTRIMS conference in Barcelona.

Patients with multiple sclerosis can develop a number of physical disabilities including problems with balance and cognition. A new study is looking at whether video games and virtual reality systems can help prevent further degeneration of these abilities.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.